Increasing the Potency and Breadth of an HIV Antibody by Using Structure-Based Rational Design, Science, vol.334, issue.6060, pp.1289-1293, 2011. ,
DOI : 10.1126/science.1213782
Infection of Specific Dendritic Cells by CCR5-Tropic Human Immunodeficiency Virus Type 1 Promotes Cell-Mediated Transmission of Virus Resistant to Broadly Neutralizing Antibodies, Journal of Virology, vol.78, issue.21, pp.11980-11987, 2004. ,
DOI : 10.1128/JVI.78.21.11980-11987.2004
Delineating Antibody Recognition in Polyclonal Sera from Patterns of HIV-1 Isolate Neutralization, Science, vol.340, issue.6133, pp.751-756, 2013. ,
DOI : 10.1126/science.1233989
Immune-Correlates Analysis of an HIV-1 Vaccine Efficacy Trial, New England Journal of Medicine, vol.366, issue.14, pp.1275-1286, 2012. ,
DOI : 10.1056/NEJMoa1113425
Effective, low-titer antibody protection against low-dose repeated mucosal SHIV challenge in macaques, Nature Medicine, vol.59, issue.8, pp.951-954, 1974. ,
DOI : 10.1038/nm.1974
International Network for Comparison of HIV Neutralization Assays: The NeutNet Report II, PLoS ONE, vol.139, issue.5, p.36438, 2012. ,
DOI : 10.1371/journal.pone.0036438.s006
HIV therapy by a combination of broadly neutralizing antibodies in humanized mice, Nature, vol.79, issue.7427, pp.118-122, 2012. ,
DOI : 10.1038/nature11604
Human Antibodies that Neutralize HIV-1: Identification, Structures, and B Cell Ontogenies, Immunity, vol.37, issue.3, pp.412-425, 2012. ,
DOI : 10.1016/j.immuni.2012.08.012
URL : http://doi.org/10.1016/j.immuni.2012.08.012
Innate Sensing of HIV-Infected Cells, PLoS Pathogens, vol.178, issue.2, p.1001284, 2011. ,
DOI : 10.1371/journal.ppat.1001284.s002
URL : https://hal.archives-ouvertes.fr/pasteur-00590930
Co-evolution of a broadly neutralizing HIV-1 antibody and founder virus, Nature, vol.372, issue.7446, pp.469-476 ,
DOI : 10.1038/nature12053
Virological Synapse-Mediated Spread of Human Immunodeficiency Virus Type 1 between T Cells Is Sensitive to Entry Inhibition, Journal of Virology, vol.84, issue.7, pp.3516-352702651, 2010. ,
DOI : 10.1128/JVI.02651-09
Antigp41 antibodies fail to block early events of virological synapses but inhibit HIV spread between T cells, AIDS, vol.23, issue.2, pp.183-188, 2009. ,
DOI : 10.1097/QAD.0b013e32831ef1a3
Neutralizing antibodies to HIV-1 induced by immunization, The Journal of Experimental Medicine, vol.72, issue.2, pp.209-223, 2013. ,
DOI : 10.1086/314452
Highly potent HIV-specific antibody neutralization in vitro translates into effective protection against mucosal SHIV challenge in vivo, Proc. Natl. Acad. Sci. USA, pp.18921-18925, 2012. ,
DOI : 10.1073/pnas.1214785109
Complex-type N-glycan recognition by potent broadly neutralizing Infection of humanized mice. HIV-1 infection of humanized mice, bNAb treatments, and analysis of viral loads and sequences were performed as described previously, Animal experiments were performed with authorization from the Institutional Review Board and the Institutional Animal Care and Use Committee at the Rockefeller University, 2012. ,
S1 shows dose?response analysis of the antiviral effect of bNAb on cell-free and cell-associated infections. Fig. S2 shows that 10E8 treatment does not impose selective pressure on HIV-1 infection in humanized mice. Online supplemental material is available at http ,
Cell-Cell Transmission Enables HIV-1 to Evade Inhibition by Potent CD4bs Directed Antibodies, PLoS Pathogens, vol.79, issue.4, 2012. ,
DOI : 10.1371/journal.ppat.1002634.s006
Antibody-based protection against HIV infection by vectored immunoprophylaxis, Nature, vol.188, issue.7379, pp.81-844688, 1038. ,
DOI : 10.1038/nature10660
A Blueprint for HIV Vaccine Discovery, Cell Host & Microbe, vol.12, issue.4, pp.396-407, 2012. ,
DOI : 10.1016/j.chom.2012.09.008
Predominant Mode of Human Immunodeficiency Virus Transfer between T Cells Is Mediated by Sustained Env-Dependent Neutralization-Resistant Virological Synapses, Journal of Virology, vol.81, issue.22, pp.12582-1259500381, 2007. ,
DOI : 10.1128/JVI.00381-07
Mechanisms of enhanced HIV spread through T-cell virological synapses, Immunological Reviews, vol.29, issue.1, pp.113-124, 2013. ,
DOI : 10.1111/imr.12022
Quantitation of human immunodeficiency virus type 1 infection kinetics, J. Virol, vol.67, pp.2182-2190, 1993. ,
Sequence and Structural Convergence of Broad and Potent HIV Antibodies That Mimic CD4 Binding, Science, vol.333, issue.6049, pp.1633-1637, 2011. ,
DOI : 10.1126/science.1207227
Impairment of T Cell Receptor-Dependent Stimulation in CD4+ Lymphocytes after Contact with Membrane-Bound HIV-1 Envelope Glycoprotein, Virology, vol.198, issue.1, pp.360-365, 1994. ,
DOI : 10.1006/viro.1994.1042
Tiered Categorization of a Diverse Panel of HIV-1 Env Pseudoviruses for Assessment of Neutralizing Antibodies, Journal of Virology, vol.84, issue.3, pp.1439-145202108, 2010. ,
DOI : 10.1128/JVI.02108-09
Cell-to-cell spread of HIV permits ongoing replication despite antiretroviral therapy, Nature, vol.31, issue.7362, pp.95-98, 2011. ,
DOI : 10.1038/nature10347
Human Immunodeficiency Virus Type 1 Elite Neutralizers: Individuals with Broad and Potent Neutralizing Activity Identified by Using a High-Throughput Neutralization Assay together with an Analytical Selection Algorithm, Journal of Virology, vol.83, issue.14, pp.7337-734800110, 2009. ,
DOI : 10.1128/JVI.00110-09
Inefficient Human Immunodeficiency Virus Replication in Mobile Lymphocytes, Journal of Virology, vol.81, issue.2, pp.1000-101201629, 2007. ,
DOI : 10.1128/JVI.01629-06
URL : https://hal.archives-ouvertes.fr/pasteur-00292736
Neutralizing antibodies generated during natural HIV-1 infection: good news for an HIV-1 vaccine?, Nature Medicine, vol.453, pp.866-870, 2009. ,
DOI : 10.1038/nm.1949
Broad neutralization coverage of HIV by multiple highly potent antibodies, Protocol G Principal Investigators, pp.466-470, 2011. ,
DOI : 10.1038/nature10373
Structural basis for germ-line gene usage of a potent class of antibodies targeting the CD4-binding site of HIV-1 gp120, Proc. Natl. Acad. Sci. USA, pp.2083-2090, 2012. ,
DOI : 10.1073/pnas.1208984109
Focused Evolution of HIV-1 Neutralizing Antibodies Revealed by Structures and Deep Sequencing, Science, vol.333, issue.6049, pp.1593-1602, 2011. ,
DOI : 10.1126/science.1207532
HIV-infected T cells are migratory vehicles for viral dissemination, Nature, vol.757, issue.7419, pp.283-2872715, 2012. ,
DOI : 10.1038/nature11398
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3470742
A mouse model for HIV-1 entry, Proc. Natl. Acad. Sci. USA, pp.15859-15864, 2012. ,
DOI : 10.1073/pnas.1213409109
SAMHD1 Restricts HIV-1 Cell-to-Cell Transmission and Limits Immune Detection in Monocyte-Derived Dendritic Cells, Journal of Virology, vol.87, issue.5, pp.2846-285602514, 2013. ,
DOI : 10.1128/JVI.02514-12
Simultaneous Cell-to-Cell Transmission of Human Immunodeficiency Virus to Multiple Targets through Polysynapses, Journal of Virology, vol.83, issue.12, pp.6234-624600282, 2009. ,
DOI : 10.1128/JVI.00282-09
URL : https://hal.archives-ouvertes.fr/pasteur-00458065
Genetic identity, biological phenotype, and evolutionary pathways of transmitted/founder viruses in acute and early HIV-1 infection, The Journal of Experimental Medicine, vol.79, issue.6, pp.1273-1289, 2009. ,
DOI : 10.1128/JVI.79.16.10108-10125.2005
Factors Associated with the Development of Cross-Reactive Neutralizing Antibodies during Human Immunodeficiency Virus Type 1 Infection, Journal of Virology, vol.83, issue.2, pp.757-76902036, 2009. ,
DOI : 10.1128/JVI.02036-08
The direct passage of animal viruses between cells, Current Opinion in Virology, vol.1, issue.5, pp.396-402, 2011. ,
DOI : 10.1016/j.coviro.2011.09.004
Broad diversity of neutralizing antibodies isolated from memory B cells in HIV-infected individuals, Nature, vol.301, issue.7238, pp.636-640, 2009. ,
DOI : 10.1038/nature07930